Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
13M
-
Shares change
-
+1.32M
-
Total reported value, excl. options
-
$122M
-
Value change
-
+$12.4M
-
Put/Call ratio
-
0.12
-
Number of buys
-
40
-
Number of sells
-
-21
-
Price
-
$9.39
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2014
73 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q2 2014.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13M shares
of 159M outstanding shares and own 8.16% of the company stock.
Largest 10 shareholders include BRIDGER MANAGEMENT, LLC (2.55M shares), JPMORGAN CHASE & CO (2.27M shares), BAKER BROS. ADVISORS LP (2.16M shares), VANGUARD GROUP INC (769K shares), Visium Asset Management, LP (630K shares), BlackRock Fund Advisors (567K shares), COLUMBUS CIRCLE INVESTORS (409K shares), JENNISON ASSOCIATES LLC (409K shares), TFS CAPITAL LLC (347K shares), and MILLENNIUM MANAGEMENT LLC (271K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.